ROY GANDOLFI: Open Payments
NPI 1740211101 · WEST VALLEY CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$375 in 21 payments from 12 companies in 2025. Trend: 2023 $686 · 2024 $4,259 · 2025 $375
Food & beverage: $375
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $58 |
| Abbott Laboratories | 2 | $45 |
| ABBVIE INC. | 2 | $43 |
| Lilly USA, LLC | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 2 | $26 |
| Dexcom, Inc. | 1 | $22 |
| SANOFI-AVENTIS U.S. LLC | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $17 |
| Boston Scientific Corporation | 1 | $16 |
Products named: JARDIANCE, SHINGRIX, FREESTYLE LIBRE 3, VOQUEZNA, QULIPTA, Dexcom G6 Transmitter, TZIELD, UBRELVY.
Industry payments across UT — which companies pay providers there.
